封面
市场调查报告书
商品编码
1508538

输血诊断市场(产品类型:仪器、试剂盒和试剂;应用:血型和疾病筛检)- 2024-2034 年全球产业分析、规模、份额、成长、趋势和预测

Blood Transfusion Diagnostics Market (Product Type: Instruments, and Kits and Reagents; and Application: Blood Grouping, and Disease Screening) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

出版日期: | 出版商: Transparency Market Research | 英文 225 Pages | 商品交期: 2-10个工作天内

价格

输血诊断市场 - 报告范围

TMR 关于全球输血诊断市场的报告研究了过去以及当前的成长趋势和机会,以获得 2024 年至 2034 年预测期内市场指标的宝贵见解。市场,考虑2024年为基准年,2034年为预测年。该报告也提供了2024年至2034年全球输血诊断市场的年复合成长率(CAGR%)。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作,其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件,以了解输血诊断市场。

市场概况
2023年市场价值 46 亿美元
2034 年市场价值 77 亿美元
复合年增长率 4.9%

该报告深入研究了全球输血诊断市场的竞争格局。全球输血诊断市场的主要参与者已被确定,并且每一位参与者都已根据各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球输血诊断市场参与者的属性。

目录

第一章:前言

第 2 章:假设与研究方法

第 3 章:执行摘要:全球市场

第 4 章:市场概述

  • 介绍
  • 概述
  • 市场动态
  • 2020-2034 年全球市场分析与预测

第 5 章:关键见解

  • 血液疾病的流行病学和输血事件的发生率
  • 输血产品定价分析
  • 政府采购政策
  • 关键产业事件(伙伴关係、协作、产品核准、併购、融资与投资)
  • COVID-19 大流行的影响

第 6 章:全球市场分析与预测:依产品类型

  • 简介与定义
  • 主要发现/进展
  • 2020-2034 年按产品类型分類的市场价值预测
    • 仪器
      • 血型鑑定仪
      • 其他的
    • 试剂盒和试剂
      • 血型试剂盒和试剂
      • 其他的
  • 按产品类型分類的市场吸引力

第 7 章:全球市场分析与预测:按应用分类

  • 简介与定义
  • 主要发现/进展
  • 2020-2034 年按应用分類的市场价值预测
    • 血型鑑定
      • ABO 血型
      • Rh 血型
      • 红血球抗体筛检
      • 扩展表型分析
      • 交叉匹配测试
    • 疾病筛检
      • 分子疾病筛检
      • 血清学疾病筛检
  • 按应用分類的市场吸引力

第 8 章:全球市场分析与预测:按最终用户

  • 简介与定义
  • 主要发现/进展
  • 2020-2034 年最终用户市场价值预测
    • 血库
    • 捐血/输血中心
    • 其他的
  • 最终用户的市场吸引力

第 9 章:全球市场分析与预测:按地区

  • 主要发现
  • 各地区市场价值预测
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 按国家/地区分類的市场吸引力

第 10 章:北美市场分析与预测

  • 我们
  • 加拿大

第 11 章:欧洲市场分析与预测

  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 欧洲其他地区

第 12 章:亚太市场分析与预测

  • 中国
  • 日本
  • 印度
  • 澳洲和纽西兰
  • 亚太地区其他地区

第 13 章:拉丁美洲市场分析与预测

  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区

第 14 章:中东和非洲市场分析与预测

  • 海湾合作委员会国家
  • 南非
  • 中东和非洲其他地区

第 15 章:竞争格局

  • 市场参与者 - 竞争矩阵(依公司层级和规模)
  • 公司简介
    • Grifols, SA
    • Werfen, SA
    • QuidelOrtho Corporation
    • Abbott
    • Bio-Rad Laboratories Inc.
    • F. Hoffman La Roche Ltd.
    • AliveDx Holdings Finance Company Ltd
    • BAG Diagnostics GmbH
    • Diasorin SpA
    • Prestige Diagnostics UK Ltd.
    • Atlas Medical GmbH
    • Lorne Laboratories Limited
Product Code: TMRGL85892

Blood Transfusion Diagnostics Market - Scope of Report

TMR's report on the global blood transfusion diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global blood transfusion diagnostics market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global blood transfusion diagnostics market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the blood transfusion diagnostics market.

Market Snapshot
Market Value in 2023US$ 4.6 Bn
Market Value in 2034US$ 7.7 Bn
CAGR4.9%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global blood transfusion diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global blood transfusion diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global blood transfusion diagnostics market.

The report delves into the competitive landscape of the global blood transfusion diagnostics market. Key players operating in the global blood transfusion diagnostics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global blood transfusion diagnostics market profiled in this report.

Key Questions Answered in Global blood transfusion diagnostics Market Report:

  • What is the sales/revenue generated by blood transfusion diagnostics across all regions during the forecast period?
  • What are the opportunities in the global blood transfusion diagnostics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Blood Transfusion Diagnostics Market - Research Objectives and Research Approach

The comprehensive report on the global blood transfusion diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global blood transfusion diagnostics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global blood transfusion diagnostics market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Blood Transfusion Diagnostics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Blood Transfusion Diagnostics Market Analysis and Forecasts, 2020-2034
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Epidemiology of Blood Disorders and Prevalence of Blood Transfusion Events
  • 5.2. Blood Transfusion Products Pricing Analysis
  • 5.3. Government Procurement Policies of Blood Transfusion Diagnostics
  • 5.4. Key Industry Events (Partnerships, Collaborations, Product Approvals, Mergers and Acquisitions, Funding and investments)
  • 5.5. Impact of COVID-19 Pandemic

6. Global Blood Transfusion Diagnostics Market Analysis and Forecasts, By Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Product Type, 2020-2034
    • 6.3.1. Instruments
      • 6.3.1.1. Blood Grouping Instruments
      • 6.3.1.2. Others
    • 6.3.2. Kits and Reagents
      • 6.3.2.1. Blood Grouping Kits and Reagents
      • 6.3.2.2. Others
  • 6.4. Market Attractiveness By Product Type

7. Global Blood Transfusion Diagnostics Market Analysis and Forecasts, By Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Application, 2020-2034
    • 7.3.1. Blood Grouping
      • 7.3.1.1. ABO Blood Grouping
      • 7.3.1.2. Rh Blood Grouping
      • 7.3.1.3. Red Blood Cell Antibody Screening
      • 7.3.1.4. Extended Phenotyping
      • 7.3.1.5. Cross Matching Tests
    • 7.3.2. Disease Screening
      • 7.3.2.1. Molecular Disease Screening
      • 7.3.2.2. Serological Disease Screening
  • 7.4. Market Attractiveness By Application

8. Global Blood Transfusion Diagnostics Market Analysis and Forecasts, By End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By End-user, 2020-2034
    • 8.3.1. Blood Banks
    • 8.3.2. Blood Donation / Transfusion Centers
    • 8.3.3. Others
  • 8.4. Market Attractiveness By End-user

9. Global Blood Transfusion Diagnostics Market Analysis and Forecasts, By Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast By Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness By Country/Region

10. North America Blood Transfusion Diagnostics Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Product Type, 2020-2034
    • 10.2.1. Instruments
      • 10.2.1.1. Blood Grouping Instruments
      • 10.2.1.2. Others
    • 10.2.2. Kits and Reagents
      • 10.2.2.1. Blood Grouping Kits and Reagents
      • 10.2.2.2. Others
  • 10.3. Market Value Forecast By Application, 2020-2034
    • 10.3.1. Blood Grouping
      • 10.3.1.1. ABO Blood Grouping
      • 10.3.1.2. Rh Blood Grouping
      • 10.3.1.3. Red Blood Cell Antibody Screening
      • 10.3.1.4. Extended Phenotyping
      • 10.3.1.5. Cross Matching Tests
    • 10.3.2. Disease Screening
      • 10.3.2.1. Molecular Disease Screening
      • 10.3.2.2. Serological Disease Screening
  • 10.4. Market Value Forecast By End-user, 2020-2034
    • 10.4.1. Blood Banks
    • 10.4.2. Blood Donation / Transfusion Centers
    • 10.4.3. Others
  • 10.5. Market Value Forecast By Country, 2020-2034
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product Type
    • 10.6.2. By Application
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Blood Transfusion Diagnostics Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Product Type, 2020-2034
    • 11.2.1. Instruments
      • 11.2.1.1. Blood Grouping Instruments
      • 11.2.1.2. Others
    • 11.2.2. Kits and Reagents
      • 11.2.2.1. Blood Grouping Kits and Reagents
      • 11.2.2.2. Others
  • 11.3. Market Value Forecast By Application, 2020-2034
    • 11.3.1. Blood Grouping
      • 11.3.1.1. ABO Blood Grouping
      • 11.3.1.2. Rh Blood Grouping
      • 11.3.1.3. Red Blood Cell Antibody Screening
      • 11.3.1.4. Extended Phenotyping
      • 11.3.1.5. Cross Matching Tests
    • 11.3.2. Disease Screening
      • 11.3.2.1. Molecular Disease Screening
      • 11.3.2.2. Serological Disease Screening
  • 11.4. Market Value Forecast By End-user, 2020-2034
    • 11.4.1. Blood Banks
    • 11.4.2. Blood Donation / Transfusion Centers
    • 11.4.3. Others
  • 11.5. Market Value Forecast By Country, 2020-2034
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Product Type
    • 11.6.2. By Application
    • 11.6.3. By End-user
    • 11.6.4. By Country

12. Asia Pacific Blood Transfusion Diagnostics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Product Type, 2020-2034
    • 12.2.1. Instruments
      • 12.2.1.1. Blood Grouping Instruments
      • 12.2.1.2. Others
    • 12.2.2. Kits and Reagents
      • 12.2.2.1. Blood Grouping Kits and Reagents
      • 12.2.2.2. Others
  • 12.3. Market Value Forecast By Application, 2020-2034
    • 12.3.1. Blood Grouping
      • 12.3.1.1. ABO Blood Grouping
      • 12.3.1.2. Rh Blood Grouping
      • 12.3.1.3. Red Blood Cell Antibody Screening
      • 12.3.1.4. Extended Phenotyping
      • 12.3.1.5. Cross Matching Tests
    • 12.3.2. Disease Screening
      • 12.3.2.1. Molecular Disease Screening
      • 12.3.2.2. Serological Disease Screening
  • 12.4. Market Value Forecast By End-user, 2020-2034
    • 12.4.1. Blood Banks
    • 12.4.2. Blood Donation / Transfusion Centers
    • 12.4.3. Others
  • 12.5. Market Value Forecast By Country, 2020-2034
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product Type
    • 12.6.2. By Application
    • 12.6.3. By End-user
    • 12.6.4. By Country

13. Latin America Blood Transfusion Diagnostics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Product Type, 2020-2034
    • 13.2.1. Instruments
      • 13.2.1.1. Blood Grouping Instruments
      • 13.2.1.2. Others
    • 13.2.2. Kits and Reagents
      • 13.2.2.1. Blood Grouping Kits and Reagents
      • 13.2.2.2. Others
  • 13.3. Market Value Forecast By Application, 2020-2034
    • 13.3.1. Blood Grouping
      • 13.3.1.1. ABO Blood Grouping
      • 13.3.1.2. Rh Blood Grouping
      • 13.3.1.3. Red Blood Cell Antibody Screening
      • 13.3.1.4. Extended Phenotyping
      • 13.3.1.5. Cross Matching Tests
    • 13.3.2. Disease Screening
      • 13.3.2.1. Molecular Disease Screening
      • 13.3.2.2. Serological Disease Screening
  • 13.4. Market Value Forecast By End-user, 2020-2034
    • 13.4.1. Blood Banks
    • 13.4.2. Blood Donation / Transfusion Centers
    • 13.4.3. Others
  • 13.5. Market Value Forecast By Country, 2020-2034
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Product Type
    • 13.6.2. By Application
    • 13.6.3. By End-user
    • 13.6.4. By Country

14. Middle East & Africa Blood Transfusion Diagnostics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Product Type, 2020-2034
    • 14.2.1. Instruments
      • 14.2.1.1. Blood Grouping Instruments
      • 14.2.1.2. Others
    • 14.2.2. Kits and Reagents
      • 14.2.2.1. Blood Grouping Kits and Reagents
      • 14.2.2.2. Others
  • 14.3. Market Value Forecast By Application, 2020-2034
    • 14.3.1. Blood Grouping
      • 14.3.1.1. ABO Blood Grouping
      • 14.3.1.2. Rh Blood Grouping
      • 14.3.1.3. Red Blood Cell Antibody Screening
      • 14.3.1.4. Extended Phenotyping
      • 14.3.1.5. Cross Matching Tests
    • 14.3.2. Disease Screening
      • 14.3.2.1. Molecular Disease Screening
      • 14.3.2.2. Serological Disease Screening
  • 14.4. Market Value Forecast By End-user, 2020-2034
    • 14.4.1. Blood Banks
    • 14.4.2. Blood Donation / Transfusion Centers
    • 14.4.3. Others
  • 14.5. Market Value Forecast By Country, 2020-2034
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Product Type
    • 14.6.2. By Application
    • 14.6.3. By End-user
    • 14.6.4. By Country

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Company Profiles
    • 15.2.1. Grifols, S.A.
      • 15.2.1.1. Company Overview
      • 15.2.1.2. Financial Overview
      • 15.2.1.3. Product Portfolio
      • 15.2.1.4. Business Strategies
      • 15.2.1.5. Recent Developments
    • 15.2.2. Werfen, S.A.
      • 15.2.2.1. Company Overview
      • 15.2.2.2. Financial Overview
      • 15.2.2.3. Product Portfolio
      • 15.2.2.4. Business Strategies
      • 15.2.2.5. Recent Developments
    • 15.2.3. QuidelOrtho Corporation
      • 15.2.3.1. Company Overview
      • 15.2.3.2. Financial Overview
      • 15.2.3.3. Product Portfolio
      • 15.2.3.4. Business Strategies
      • 15.2.3.5. Recent Developments
    • 15.2.4. Abbott
      • 15.2.4.1. Company Overview
      • 15.2.4.2. Financial Overview
      • 15.2.4.3. Product Portfolio
      • 15.2.4.4. Business Strategies
      • 15.2.4.5. Recent Developments
    • 15.2.5. Bio-Rad Laboratories Inc.
      • 15.2.5.1. Company Overview
      • 15.2.5.2. Financial Overview
      • 15.2.5.3. Product Portfolio
      • 15.2.5.4. Business Strategies
      • 15.2.5.5. Recent Developments
    • 15.2.6. F. Hoffman La Roche Ltd.
      • 15.2.6.1. Company Overview
      • 15.2.6.2. Financial Overview
      • 15.2.6.3. Product Portfolio
      • 15.2.6.4. Business Strategies
      • 15.2.6.5. Recent Developments
    • 15.2.7. AliveDx Holdings Finance Company Ltd
      • 15.2.7.1. Company Overview
      • 15.2.7.2. Financial Overview
      • 15.2.7.3. Product Portfolio
      • 15.2.7.4. Business Strategies
      • 15.2.7.5. Recent Developments
    • 15.2.8. BAG Diagnostics GmbH
      • 15.2.8.1. Company Overview
      • 15.2.8.2. Financial Overview
      • 15.2.8.3. Product Portfolio
      • 15.2.8.4. Business Strategies
      • 15.2.8.5. Recent Developments
    • 15.2.9. Diasorin S.p.A.
      • 15.2.9.1. Company Overview
      • 15.2.9.2. Financial Overview
      • 15.2.9.3. Product Portfolio
      • 15.2.9.4. Business Strategies
      • 15.2.9.5. Recent Developments
    • 15.2.10. Prestige Diagnostics U.K. Ltd.
      • 15.2.10.1. Company Overview
      • 15.2.10.2. Financial Overview
      • 15.2.10.3. Product Portfolio
      • 15.2.10.4. Business Strategies
      • 15.2.10.5. Recent Developments
    • 15.2.11. Atlas Medical GmbH
      • 15.2.11.1. Company Overview
      • 15.2.11.2. Financial Overview
      • 15.2.11.3. Product Portfolio
      • 15.2.11.4. Business Strategies
      • 15.2.11.5. Recent Developments
    • 15.2.12. Lorne Laboratories Limited
      • 15.2.12.1. Company Overview
      • 15.2.12.2. Financial Overview
      • 15.2.12.3. Product Portfolio
      • 15.2.12.4. Business Strategies
      • 15.2.12.5. Recent Developments

List of Tables

  • Table 01: Global Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Type, 2020-2034
  • Table 02: Global Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Instrument, 2020-2034
  • Table 03: Global Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Kits and Reagents, 2020-2034
  • Table 04: Global Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 05: Global Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Blood Grouping, 2020-2034
  • Table 06: Global Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Disease Screening, 2020-2034
  • Table 07: Global Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 08: Global Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Region, 2020-2034
  • Table 09: North America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Country, 2020-2034
  • Table 10: North America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2020-2034
  • Table 11: North America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Instruments, 2020-2034
  • Table 12: North America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Kits and Reagents, 2020-2034
  • Table 13: North America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 14: North America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Blood Grouping, 2020-2034
  • Table 15: North America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Disease Screening, 2020-2034
  • Table 16: North America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 17: Europe Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 18: Europe Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2020-2034
  • Table 19: Europe Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Instruments, 2020-2034
  • Table 20: Europe Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Kits and Reagents, 2020-2034
  • Table 21: Europe Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 22: Europe Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Blood Grouping, 2020-2034
  • Table 23: Europe Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Disease Screening, 2020-2034
  • Table 24: Europe Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 25: Asia Pacific Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 26: Asia Pacific Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2020-2034
  • Table 27: Asia Pacific Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Instruments, 2020-2034
  • Table 28: Asia Pacific Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Kits and Reagents, 2020-2034
  • Table 29: Asia Pacific Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 30: Asia Pacific Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Blood Grouping, 2020-2034
  • Table 31: Asia Pacific Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Disease Screening, 2020-2034
  • Table 32: Asia Pacific Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 33: Latin America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 34: Latin America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2020-2034
  • Table 35: Latin America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Instruments, 2020-2034
  • Table 36: Latin America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Kits and Reagents, 2020-2034
  • Table 37: Latin America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 38: Latin America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Blood Grouping, 2020-2034
  • Table 39: Latin America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Disease Screening, 2020-2034
  • Table 40: Latin America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 41: Middle East & Africa Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 42: Middle East & Africa Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2020-2034
  • Table 43: Middle East & Africa Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Instruments, 2020-2034
  • Table 44: Middle East & Africa Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Kits and Reagents, 2020-2034
  • Table 45: Middle East & Africa Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 46: Middle East & Africa Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Blood Grouping, 2020-2034
  • Table 47: Middle East & Africa Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Disease Screening, 2020-2034
  • Table 48: Middle East & Africa Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034

List of Figures

  • Figure 01: Global Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Blood Transfusion Diagnostics Market Value Share, by Product Type, 2023
  • Figure 03: Global Blood Transfusion Diagnostics Market Value Share, by Application, 2023
  • Figure 04: Global Blood Transfusion Diagnostics Market Value Share, by End-user, 2023
  • Figure 05: Global Blood Transfusion Diagnostics Market Value Share, by Region, 2023
  • Figure 06: Global Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2023 and 2034
  • Figure 07: Global Blood Transfusion Diagnostics Market Share Analysis, by Product Type, 2023
  • Figure 08: Global Blood Transfusion Diagnostics Market Share Analysis, by Product Type, 2034
  • Figure 09: Global Blood Transfusion Diagnostics Market Attractiveness Analysis, by Product Type, 2024-2034
  • Figure 10: Global Blood Transfusion Diagnostics Market Value (US$ Mn), by Instruments, 2020-2034
  • Figure 11: Global Blood Transfusion Diagnostics Market Value Share Analysis, by Instruments, 2023 and 2034
  • Figure 12: Global Blood Transfusion Diagnostics Market Value (US$ Mn), by Kits and Reagents, 2020-2034
  • Figure 13: Global Blood Transfusion Diagnostics Market Value Share Analysis, by Kits & Reagents, 2023 and 2034
  • Figure 14: Global Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
  • Figure 15: Global Blood Transfusion Diagnostics Market Share Analysis, by Application, 2023
  • Figure 16: Global Blood Transfusion Diagnostics Market Share Analysis, by Application, 2034
  • Figure 17: Global Blood Transfusion Diagnostics Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 18: Global Blood Transfusion Diagnostics Market Value (US$ Mn), by Blood Grouping, 2020-2034
  • Figure 19: Global Blood Transfusion Diagnostics Market Value Share Analysis, by Blood Grouping, 2023 and 2034
  • Figure 20: Global Blood Transfusion Diagnostics Market Value (US$ Mn), by Disease Screening, 2020-2034
  • Figure 21: Global Blood Transfusion Diagnostics Market Value Share Analysis, by Disease Screening, 2023 and 2034
  • Figure 22: Global Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 23: Global Blood Transfusion Diagnostics Market Share Analysis, by End-user, 2023
  • Figure 24: Global Blood Transfusion Diagnostics Market Share Analysis, by End-user, 2034
  • Figure 25: Global Blood Transfusion Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 26: Global Blood Transfusion Diagnostics Market Value (US$ Mn), by Blood Banks, 2020-2034
  • Figure 27: Global Blood Transfusion Diagnostics Market Value Share Analysis, by Blood Banks, 2023 and 2034
  • Figure 28: Global Blood Transfusion Diagnostics Market Value (US$ Mn), by Hospitals, 2020-2034
  • Figure 29: Global Blood Transfusion Diagnostics Market Value Share Analysis, by Hospitals, 2023 and 2034
  • Figure 30: Global Blood Transfusion Diagnostics Market Value (US$ Mn), by Blood Donation / Transfusion Centers, 2020-2034
  • Figure 31: Global Blood Transfusion Diagnostics Market Value Share Analysis, by Blood Donation / Transfusion Centers, 2023 and 2034
  • Figure 32: Global Blood Transfusion Diagnostics Market Value (US$ Mn), by Others, 2020-2034
  • Figure 33: Global Blood Transfusion Diagnostics Market Value Share Analysis, by Others, 2023 and 2034
  • Figure 34: Global Blood Transfusion Diagnostics Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 35: Global Blood Transfusion Diagnostics Market Share Analysis, by Region, 2023
  • Figure 36: Global Blood Transfusion Diagnostics Market Share Analysis, by Region, 2034
  • Figure 37: Global Blood Transfusion Diagnostics Market Attractiveness Analysis, by Region, 2023-2034
  • Figure 38: North America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 39: North America Blood Transfusion Diagnostics Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 40: North America Blood Transfusion Diagnostics Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 41: North America Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2023 and 2034
  • Figure 42: North America Blood Transfusion Diagnostics Market Attractiveness Analysis, by Product Type, 2024-2034
  • Figure 43: North America Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
  • Figure 44: North America Blood Transfusion Diagnostics Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 45: North America Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 46: North America Blood Transfusion Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 47: Europe Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 48: Europe Blood Transfusion Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 49: Europe Blood Transfusion Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 50: Europe Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2023 and 2034
  • Figure 51: Europe Blood Transfusion Diagnostics Market Attractiveness Analysis, by Product Type, 2024-2034
  • Figure 52: Europe Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
  • Figure 53: Europe Blood Transfusion Diagnostics Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 54: Europe Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 55: Europe Blood Transfusion Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 56: Asia Pacific Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 57: Asia Pacific Blood Transfusion Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 58: Asia Pacific Blood Transfusion Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 59: Asia Pacific Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2023 and 2034
  • Figure 60: Asia Pacific Blood Transfusion Diagnostics Market Attractiveness Analysis, by Product Type, 2024-2034
  • Figure 61: Asia Pacific Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
  • Figure 62: Asia Pacific Blood Transfusion Diagnostics Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 63: Asia Pacific Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 64: Asia Pacific Blood Transfusion Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 65: Latin America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 66: Latin America Blood Transfusion Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 67: Latin America Blood Transfusion Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 68: Latin America Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2023 and 2034
  • Figure 69: Latin America Blood Transfusion Diagnostics Market Attractiveness Analysis, by Product Type, 2024-2034
  • Figure 70: Latin America Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
  • Figure 71: Latin America Blood Transfusion Diagnostics Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 72: Latin America Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 73: Latin America Blood Transfusion Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 74: Middle East & Africa Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 75: Middle East & Africa Blood Transfusion Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 76: Middle East & Africa Blood Transfusion Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 77: Middle East & Africa Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2023 and 2034
  • Figure 78: Middle East & Africa Blood Transfusion Diagnostics Market Attractiveness Analysis, by Product Type, 2024-2034
  • Figure 79: Middle East & Africa Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
  • Figure 80: Middle East & Africa Blood Transfusion Diagnostics Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 81: Middle East & Africa Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 82: Middle East & Africa Blood Transfusion Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034